article_metadata: Ramon Diez-Feijóo Juan Jose Rodríguez-Sevilla Concepcion Fernández-Rodríguez Solange Flores Carmen Raya Ana Ferrer Luis Colomo Antonio Salar
article_metadata: 10.3389/fimmu.2021.798251
article_metadata: Front Immunol
article_metadata: 2022 Jan 10;12:798251.
article_metadata: waldenström’s macroglobulinemia agranulocytosis bendamustine immunoglobulin rituximab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/35082788/
article_metadata: Agranulocytosis / drug therapy Antineoplastic Combined Chemotherapy Protocols / adverse effects Immunoglobulins, Intravenous / therapeutic use
article_metadata: Agranulocytosis / drug therapy Antineoplastic Combined Chemotherapy Protocols / adverse effects Immunoglobulins, Intravenous / therapeutic use Case Reports Aged Agranulocytosis / chemically induced Agranulocytosis / immunology Antineoplastic Combined Chemotherapy Protocols / therapeutic use Bendamustine Hydrochloride / administration & dosage Bendamustine Hydrochloride / adverse effects Dose-Response Relationship, Drug Humans Immunoglobulins, Intravenous / administration & dosage Male Rituximab / administration & dosage Rituximab / adverse effects Treatment Outcome Waldenstrom Macroglobulinemia / drug therapy Immunoglobulins, Intravenous Rituximab Bendamustine Hydrochloride
article_metadata: PMC8784545
article_metadata: 35082788
article_metadata: Case Report: High Doses of Intravenous Immunoglobulins as a Successful Treatment for Late Onset Immune Agranulocytosis After Rituximab Plus Bendamustine
article_metadata: 2022